STAT

The U.S. gets a D- in the coronavirus fight. That stands for ‘disorganization,’ and it’s fixable

What’s missing in our #coronavirus response is an appreciation of the value of data, and humanity’s mastery of it, as the one weapon we have against an out-of-control virus.
President Trump during one of the daily briefings on the coronavirus.

NEW YORK — Leora Horwitz has seen other disasters. Now the director of the Center for Healthcare Innovation and Delivery Science at New York University Langone Medical Center, she was a resident in a New York intensive care unit on Sept. 11, 2001, and chief resident during the blackout two years later. But working in the hospital to fight the novel coronavirus that has stopped the U.S. economy is like nothing she has ever experienced.

Normally transferring a single patient to the intensive care unit, or watching one die, is enough to ruin her week. Now, she is transferring one patient in five.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks